Jason Aryeh, Director at Aralez Pharmaceuticals Inc. (ARLZ), sold 777,370 shares at $1.41 ($1.1M) on 2017-05-23, disclosed to the SEC on 2017-05-24.
Open-market sale of $1.1M ARLZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.56 | 51,041 | $80K | 7.1% |
| 2 | $1.56 | 51,041 | $80K | 7.1% |
| 3 | $1.42 | 233,468 | $332K | 29.7% |
| 4 | $1.42 | 233,468 | $332K | 29.7% |
| 5 | $1.41 | 104,176 | $147K | 13.2% |
| 6 | $1.41 | 104,176 |
| $147K |
| 13.2% |
| Total | $1.44 avg | 777,370 | $1.1M | 100% |
| Filing → |
| OBIO | BUY | 2026-05-19 | $35K | — | Filing → |
| LGND | SELL | 2025-09-24 | $3.4M | — | Filing → |
| OBIO | BUY | 2025-09-19 | $2K | — | Filing → |